Introduction {#s1}
============

*Staphylococcus aureus* is an opportunistic pathogen that can potentially cause a wide range of infections. It is a leading cause of bacteremia and represents a significant global health problem (Weiner et al., [@B46]). *S. aureus* bacteremia (SAB) is often associated with severe metastatic infections, such as infective endocarditis, septic arthritis and osteomyelitis and complications, such as sepsis and septic shock, which lead to adverse outcomes that are challenging to manage (Shorr et al., [@B39]; Wyllie, [@B48]).

The incidence of SAB is difficult to determine and there are major geographical differences that reflect discrepancies in health care systems and infection control practices. In developed countries, the estimated incidence 80--190 cases per 100,000 inhabitants per year (Laupland, [@B20]; Le Moing et al., [@B21]). Despite the improvements in SAB management, including greater understanding of this infection and mandatory surveillance implemented in several countries over recent decades, SAB still causes significant morbidity and mortality, with an associated early mortality that appears to have plateaued at approximately 20--30% (van Hal et al., [@B42]). Certainly, little is known about global SAB epidemiology in terms of the circulating clones causing SAB in different patient subgroups, such as adults and children, or those most commonly found in the community or hospital settings. Because it is becoming progressively more difficult to differentiate between healthcare-associated and community-acquired infections due to changes in the complexity of present health care systems, it is important to identify the specific clones that are traditionally associated with the community but may be entering hospitals and replacing common nosocomial clones, and vice versa. Moreover, it would be especially interesting to study clonality taking into account that bacterial phenotype and genotype have been shown to have a possible influence on infection outcome, since different clones can adopt different strategies to overcome host responses and cause severe pathology (Recker et al., [@B32]). The overall mortality rate from SAB varies depending on the primary focus of infection (the highest rates occur in patients with infective endocarditis and pulmonary infections, and the lowest in patients with catheter-related infections) and on the complications deriving from SAB. This association makes it necessary to regard SAB not as a single entity, but as a heterogeneous group of infections that can evolve differently and therefore require source-specific management (van Hal et al., [@B42]). However, the characteristics of the most common clones causing SAB according to source of infection remain unknown. Furthermore, determining the role of particular genetic backgrounds (clonality and virulence) in bloodstream infections caused by *S. aureus* has become a real challenge due to the diversity, redundancy and host specificity of the virulence factors.

The aim of the present study was to explore the molecular characteristics of *S. aureus* strains causing bacteremia in order to provide an epidemiological overview of the circulating clones causing bloodstream infection and to analyze the possible association between virulence and the most common sources of bacteremia.

Materials and methods {#s2}
=====================

Data collection
---------------

A total of 785 strains causing bacteremia with different source and 48 colonization strains collected over a period of 15 years (2002--2017) were analyzed. These strains were obtained from different sources in hospitals geographically distant from each other spread across the territory of Spain (Table [1](#T1){ref-type="table"}). Specifically, these strains were identified in 10 different collections: six were single-center studies developed at the Hospital 12 de Octubre in Madrid, and the remaining four corresponded to multi-center studies developed at various Spanish hospitals (Muñoz-Gallego et al., [@B28]; San-Juan et al., [@B35]; Fernández-Hidalgo et al., [@B9]). The main focus and objective of the studies for which these strains were collected was source of staphylococcal bacteremia, mainly endocarditis (*N* = 214), catheter-related bacteremia (CRB) (*N* = 212), skin and soft tissue infections (SSTI) (*N* = 66), and bone and joint infections (*N* = 100). Eight of these collections corresponded to SAB infections in adults, and two in children (\< 15 years of age). The percentage of MRSA strains included in each collection varied. The studies were approved by the ethics committee of the University Hospital 12 de Octubre (Madrid, Spain). It was not considered necessary to obtain written informed consent because the participants were anonymized (IRH-ANT-2013-01).

###### 

Description of the bacteremia-producing strain collections included in the study.

  **Source**                                        **Period**   **Participating cities**                                **Participating hospitals[^\*^](#TN4){ref-type="table-fn"}**   **Number of strains**   **Age population**    **MRSA (%)**   **Commentary**                                                         **References**
  ------------------------------------------------- ------------ ------------------------------------------------------- -------------------------------------------------------------- ----------------------- --------------------- -------------- ---------------------------------------------------------------------- ---------------------------------
  Endocarditis                                      2013--2016   Malaga, Seville, Madrid, Barcelona, Santander, Bilbao   15                                                             210                     Adults                19.0           Prospective study                                                      Fernández-Hidalgo et al., [@B9]
  Catheter                                          2011--2014   Madrid, Barcelona, Seville                              5                                                              80                      Adults                0.0            Prospective study including only MSSA strains                          San-Juan et al., [@B36]
  Various sources[^a^](#TN1){ref-type="table-fn"}   2002--2010   Madrid                                                  1                                                              111                     Children              3.6            Retrospective studies                                                  --
  Various sources[^b^](#TN2){ref-type="table-fn"}   2009--2010   Madrid, Barcelona, Palma de Mallorca, A Coruña          5                                                              91                      Children              12.1           Prospective study                                                      --
  Various sources[^b^](#TN2){ref-type="table-fn"}   2006--2010   Madrid                                                  1                                                              45                      Adults and children   51.1           Retrospective study including recurrent bacteremia. Children *n* = 3   --
  Various sources[^d^](#TN3){ref-type="table-fn"}   2010--2011   Madrid                                                  1                                                              111                     Adults                24.3           Retrospective study                                                    Viedma et al., [@B45]
  Various sources[^e^](#TN2){ref-type="table-fn"}   2012--2014   Madrid                                                  1                                                              59                      Adults                100.0          Retrospective study including only MRSA strains                        --
  Bone and joint infections                         2005--2015   Madrid                                                  1                                                              49                      Adults                71, 4          Retrospective study                                                    Muñoz-Gallego et al., [@B28]
  Bone and joint infections                         2016         Madrid                                                  7                                                              29                      Adults                20, 7          Prospective study                                                      --
  Colonization                                      2012         Madrid                                                  1                                                              48                      Adults                5.8            Prospective study of colonization strains from healthy carriers        López-aguilera et al., [@B23]

*Catheter-related, congenital, skin and soft tissue infections, osteoarticular, unknown*.

*Catheter-related, skin and soft tissue infections, osteoarticular, unknown*.

*Catheter-related, skin and soft tissue infections, osteoarticular, endocarditis, urinary tract infection, respiratory, unknown*.

*Participant Hospitals: University Hospital 12 de Octubre, University Hospital de La Princesa, University Hospital Puerta del Hierro, University Hospital La Paz (Comunidad de Madrid); University Hospital A Coruña (Galicia); University Hospital Marqués de Valdecilla (Cantabria); University Hospital Son Espases (Islas Baleares); University Hospital Cruces (País Vasco); University Hospital Vall d'Hebron, Hospital Universitario de Bellvitge, Hospital de la Santa Creu y Sant Pau, Hospital de San Pedro, Hospital Germans Trias i Pujol, Hospital de Barcelona, Hospital Parc Tauli (Cataluña); Hospital Universitario Virgen de la Macarena, Hospital Universitario Virgen del Rocío, Hospital Universitario Virgen de la Victoria (Andalucía)*.

Cases were classified according to acquisition: healthcare-associated (HA) or community-acquired (CA). HA included both nosocomial cases with a positive blood culture obtained from patients who had been hospitalized for 48 h or longer (Garner et al., [@B13]) and healthcare-associated cases following Friedman et al.\'s criteria (Friedman et al., [@B12]). CA cases were those with a positive blood culture obtained at the time of hospital admission or within 48 h after hospital admission.

Methicillin resistance was defined on the basis of results of microdilution techniques, cefoxitin susceptibility testing and/or the presence of the *mecA* gene.

Molecular studies
-----------------

Blood cultures were processed with an automated blood culture system (BACTEC 9240, Becton Dickinson Microbiological System, USA). Automatic microdilution techniques were used for identification and susceptibility testing of isolates. Bacterial DNA was extracted using commercial extraction kits (Qiagen, Germany) according to the manufacturer\'s recommendations. DNA microarrays (Alere, Germany; Monecke et al., [@B26]) covering 334 target sequences and approximately 187 different genes that included species-specific markers, antimicrobial resistance genes, exotoxins, genes encoding microbial surface components recognizing adhesive matrix molecules (MCSCRAMMs), capsule genes, clonal complexes (CC) and *agr* group typing markers were run on the whole collection of strains. Those cases with ambiguous array results were considered as missing values for further analysis.

Only genes found with a frequency of between 5 and 95% in the whole collection were considered for statistical analysis.

Statistical analysis
--------------------

Categorical variables were compared using the chi-squared or Fisher\'s exact test, as appropriate. Significance levels of DNA microarray results were corrected using the Bonferroni correction for multiple tests. Pairwise comparisons of the main CCs, *agr* types and virulence genes were performed with source of bacteremia. Potential associations were investigated by univariate and multivariate logistic regression, in which CCs, *agr* types and virulence factors were considered as independent dichotomous variables, and source of bacteremia as the dependent variable. For multivariate analysis, variables with a *p*-value \<0.1 in the univariate analysis were included in a backward stepwise algorithm. All statistical tests were two-tailed and a *p*-value of \<0.05 was considered statistically significant. Analyses were performed using the SPSS statistical package, version 21.0 (SPSS Inc., Chicago, IL).

Results {#s3}
=======

A total of 785 *S. aureus* strains causing bacteremia and 48 *S. aureus* colonizing strains were characterized in this study with the DNA microarray. Of a total of 187 genes included in the array, 67 genes were excluded from further analysis. Twenty one genes because they were found in almost all of the strains (\>95%): *sarA*(99.5%)*, saeS*(98.4%)*, vraS*(99.7%)*, lukF*(96.7%)*, hl*(97.5%)*, hld*(99.3%)*, sspA*(99.8%)*, sspB*(100%)*, sspP*(99.8%)*, icaA*(99.6%)*, icaC*(98.4%)*, icaD*(99.5%)*, clfA*(99.6%)*, clfB*(99.4%)*, ebpS*(99.4%)*, eno*(99.5%)*, fnbA*(98.1%)*, map*(97.6%)*, sdrC*(99.3%) and *isdA*(99.6%); and 47 genes because they were absent from almost all of the strains (\< 5%): *ermA*(4.7%)*, ermB*(0.3%)*, lnuA*(0.7%)*, mefA*(0%)*, vatA*(0%)*, vatB*(0%)*, vgaA*(2.6%)*, vgaB*(0%)*, aacA-aphD*(3.9%)*, dfrS1*(2.5%)*, fusB*(0%)*, fusC*(0.8%)*, tetK*(2.2%)*, tetM*(2.1%)*, cat*(0.8%)*, cfr*(0.1%)*, fexA*(0.2%)*, qacA*(0.2%)*, qacC*(2.2%)*, vanA*(0%)*, vanB*(0%)*, vanZ*(0%)*, seb*(3.6%)*, see*(0%)*, seh*(4.6%)*, sej*(3.6%)*, sek*(3.4%)*, seq*(3.1%)*, ser*(3.4%)*, pvl*(1.8%), *etA*(2.5%)*, etB*(0.8%)*, etD*(3.1%)*, edinA*(0.6%)*, edinB*(3.3%)*, edinC*(0.7%)*, ACME cluster*(0.5%)*, arcA-SCC*(0.2%)*, arcB-SCC*(0.1%)*, arc-SCC*(0.1%)*, arcD-SCC*(3.6%)*, cap1*(0.7%), and *bap*(0.1%). Nine additional genes were discarded due to an unacceptable number of missing values (\>30%): *mecC*(55%), *mecR*(56.2%)*, merA*(53.3%)*, merB*(39.5%)*, fosBplasmid*(62.8%)*, lukM*(52.8%)*, lukY*(51.3%)*, setC-selX*(52.3%)*, setB3*(51.5%)*, setB2*(51.7%)*, setB1*(52.6%)*, fnbB*(51.3%), and *sdrD*(51.6%).

The main CCs detected in this study were: CC5 (30.8%), CC30 (20.3%), CC45 (8.3%), CC8 (8.4%), CC15 (7.5%) and CC22 (5.9%). In addition, up to 22 minor CCs were also detected: CC398 (2.4%), CC121 (2.4%), CC25 (2.2%), CC9 (1.7%), CC97 (1.6%), CC6 (1.3%), CC1 (1.1%), CC7 (1.1%), CC188 (1.0%), CC101, CC10, CC49, CC59, CC509, CC20, CC12, CC75, CC96, CC395, CC522, CC707 and CC1021 (\<1%; Table [2](#T2){ref-type="table"}). *agrII* type was the most common (41.7%), followed by *agrI* (33.7%) and *agrIII* (22.2%).

###### 

Distribution of *S. aureus* clonal complexes according to place of acquisition, methicillin resistance and age of population.

       **Place of acquisition**[^\*^](#TN5){ref-type="table-fn"}   **Methicillin resistance**   **Age (adult)**                                                                    
  ---- ----------------------------------------------------------- ---------------------------- ----------------- ------------ ------------ ------------- ------------ ----------- -------------
  5    193 (35.6)                                                  50 (20.2)                    \<**0.001**       90 (14.7)    162 (79.4)   \<**0.001**   213 (34.2)   39 (20.0)   \<**0.001**
  8    38 (7.0)                                                    21 (8.5)                     0.474             42 (6.9)     20 (9.8)     0.179         45 (7.2)     17 (8.7)    0.501
  15   40 (7.4)                                                    21 (8.5)                     0.598             61 (10.0)    0 (0.0)      \<**0.001**   43 (6.9)     18 (9.2)    0.293
  22   35 (6.5)                                                    11 (4.4)                     0.249             39 (6.4)     9 (4.4)      0.291         39 (6.3)     9 (4.6)     0.379
  30   101 (18.6)                                                  58 (23.4)                    0.126             165 (26.9)   1 (0.5)      \<**0.001**   113 (18.2)   53 (27.2)   **0.008**
  45   42 (7.7)                                                    23 (9.3)                     0.473             65 (10.6)    4 (2.0)      \<**0.001**   50 (8.0)     19 (9.7)    0.462

*27 strains did not have place of acquisition data available*.

*Only the major clones are shown. Other clones detected in this study were: CC1(1.1%), CC6(1.3%), CC7(1.1%), CC9(1.7%), CC10(0.6%), CC12(0.2%), CC20(0.4%), CC25(2.2%), CC49(0.6%), CC59(0.6%), CC75(0.1%), CC96(0.1%), CC97(1.6%), CC101(0.7%), CC121(2.4%), CC188(1.0%), CC395(0.1%), CC398(2.4%), CC509(0.5%), CC522(0.1%), CC707(0.1%) and CC1021(0.1%)*.

*Statistically significant results are highlighted in bold*.

*CC, clonal complex; HA, healthcare-associated; CA, community-associated; MSSA, methicillin-susceptible S. aureus; MRSA, methicillin-resistant S. aureus*.

Distribution of *S. aureus* strains by CC and *agr* type according to acquisition, methicillin resistance and age of population
-------------------------------------------------------------------------------------------------------------------------------

### Healthcare-associated vs. community-acquired

In our collection, there was a higher proportion of HA strains (68.4%) compared to CA strains, which accounted for 31.6%. Healthcare-associated strains were assigned to 26 different CCs, with CC5 (35.6%) being the most common, followed by CC30 (18.6%). The CC diversity was slightly lower among CA strains, which were assigned to 23 CCs, with CC30 (23.4%) and CC5 (20.2%) being the ones most commonly found (Table [2](#T2){ref-type="table"}). Although most clones circulated in the healthcare and community settings, a higher proportion of CC5 was found among HA than among CA strains (35.6 vs. 20.2%, *p* \< 0.001; Table [2](#T2){ref-type="table"}).

The distribution of *agr* types is presented in Table [3](#T3){ref-type="table"}. Note that while *agrI* was the main *agr* type among CA strains (31.0% vs. 39.2%, *p*: 0.030), *agrII* was associated with HA acquisition, (46.6 vs. 31.8%, *p* \< 0.001).

###### 

Distribution of *agr* types according to place of acquisition, methicillin resistance and age of population.

             **Place of acquisition**[^\*^](#TN7){ref-type="table-fn"}   **Methicillin resistance**   **Adult age**                                                                    
  ---------- ----------------------------------------------------------- ---------------------------- --------------- ------------ ------------ ------------- ------------ ----------- -------------
  *agrI*     169 (31.0)                                                  96 (39.2)                    **0.030**       238 (38.6)   37 (18.4)    \<**0.001**   206 (33.3)   69 (34.7)   0.728
  *agrII*    254 (46.6)                                                  78 (31.8)                    \<**0.001**     179 (29.1)   162 (80.6)   \<**0.001**   276 (44.7)   65 (32.7)   \<**0.001**
  *agrIII*   113 (20.7)                                                  61 (24.9)                    0.225           179 (29.1)   2 (1.0)      \<**0.001**   123 (19.9)   58 (29.1)   **0.008**
  *agrIV*    9 (1.7)                                                     10 (4.1)                     0.070           20 (3.2)     0 (0.0)      **0.006**     13 (2.1)     7 (3.5)     0.390

*27 strains did not have data for place of acquisition available*.

*In the whole collection there were 16 non-typable agr strains*.

*Statistically significant results are highlighted in bold*.

*HA, healthcare-associated; CA, community-associated; MSSA, methicillin-susceptible S. aureus; MRSA, methicillin-resistant S. aureus*.

### Methicillin resistance

Methicillin resistance was observed in 24.7% of the strains. Eleven different CCs were detected in this group, with CC5 being the main clone (79.4%). By contrast, among the MSSA strains, all the CCs detected in our collection were represented (*N* = 28) and showed a higher clonal diversity than MRSA strains. The major clones detected among MSSA strains were CC30 (26.5%), CC5 (14.5%), CC45 (10.5%) and CC15 (10.0%). A comparison of the two groups revealed that only CC5 was associated with methicillin resistance (14.7 vs. 79.4%, *p* \< 0.001), whereas CC30, CC45 and CC15 were correlated with MSSA strains (*p* \< 0.001; Table [2](#T2){ref-type="table"}).

With respect to *agr* type, *agrII* type was observed to be significantly associated with MRSA strains (29.1 vs. 80.6%, *p* \< 0.001), whereas, *agrI* was associated with MSSA strains (38.6 vs. 18.4%, *p* \< 0.001; Table [3](#T3){ref-type="table"}).

### Adult vs. child population

While 28 CCs detected in this study were represented among strains isolated from adults, lower CC diversity was detected in children, with only 19 CCs identified. A comparison of clonality in the adult and children populations revealed that while CC5 was associated with strains from adults (34.2 vs. 20.0%, *p* \< 0.001), CC30 was significantly related to strains from the child population (18.2 vs. 27.2%, *p* \< 0.008; Table [2](#T2){ref-type="table"}).

The distribution of *agr* types by patient age is shown in Table [3](#T3){ref-type="table"}. This analysis showed a significant association between *agrII* and strains from adults (44.7 vs. 32.7%, *p* \< 0.001), while *agrIII* was associated with the child population (19.9 vs. 29.1%, *p* \< 0.008).

Clonal complex diversity, *agr* type and virulence genes among *S. aureus* strains from different sources of bacteremia
-----------------------------------------------------------------------------------------------------------------------

The main objective was to explore the distribution of CCs and virulence genes according to source of bacteremia. A collection of *S. aureus* strains from healthy carriers was also added to the analysis in order to evaluate potential differences between colonizing and bacteremic strains.

Remarkably, CC5 and *agrII* predominated in SAB from osteoarticular infections (Tables [4A](#T4A){ref-type="table"},[B](#T4B){ref-type="table"}). When we focused on antibiotic resistance genes, significant differences were identified in strains from different sources of infection for the *mecA, msrA, aadD, aphA3*, and *sat* genes (Tables [4A](#T4A){ref-type="table"},[B](#T4B){ref-type="table"}). Our results seemed to indicate a higher proportion of these resistance genes among osteoarticular infections compared with other bacteremia sources. In general, significant differences for source of bacteremia and colonization were also detected in virulence genes, such as *sea, sed, hla, undisrupted hlb, splE, cna, fib*, and *isaB* among others.

###### 

Frequency of clonal complexes, *agr* type, resistance and virulence genes according to different sources of infection.

  **Variable**                                     **Colonization (*N* = 48) *n* (%)**   **CRB (*N* = 212) *n* (%)**   **Endocarditis (*N* = 214) *n* (%)**   **SSTI (*N* = 66) *n* (%)**   **Osteoarticular (*N* = 100) *n* (%)**   ***P*-value[^a^](#TN10){ref-type="table-fn"}**
  ------------------------------------------------ ------------------------------------- ----------------------------- -------------------------------------- ----------------------------- ---------------------------------------- ------------------------------------------------
  **CC**[^\*^](#TN9){ref-type="table-fn"}                                                                                                                                                                                            
  5                                                9 (19.1)                              65 (31.3)                     47 (22.0)                              19 (29.7)                     51 (51.5)                                \<**0.001**
  8                                                2 (4.3)                               14 (6.7)                      22 (10.3)                              5 (7.8)                       3 (3.0)                                  0.236
  15                                               3 (6.4)                               15 (7.2)                      20(9.3)                                10 (15.6)                     4 (4.0)                                  0.192
  22                                               2 (4.3)                               15 (7.2)                      16 (7.5)                               1 (1.6)                       7 (7.1)                                  0.435
  30                                               11 (23.4)                             44 (21.2)                     41 (19.2)                              11 (17.2)                     11 (11.1)                                0.263
  45                                               4 (8.5)                               19 (9.1)                      19 (8.9)                               3 (4.7)                       6 (6.1)                                  0.736
  ***agr*** **TYPES**                                                                                                                                                                                                                
  *agrI*                                           17 (36.2)                             72 (34.1)                     81 (38.6)                              18 (28.1)                     28 (28.3)                                0.342
  *agrII*                                          14 (29.8)                             90 (42.7)                     77 (36.7)                              31 (48.4)                     55 (55.6)                                0.008
  *agrIII*                                         12(25.5)                              47 (22.3)                     46 (21.9)                              14 (21.9)                     12 (12.1)                                0.184
  *agrIV*                                          4 (8.5)                               2 (0.9)                       6 (2.9)                                1 (1.6)                       4 (4.0)                                  0.087
  **ANTIBIOTIC RESISTANCE GENES**                                                                                                                                                                                                    
  *mecA*                                           3 (6.3)                               54 (25.5)                     39 (18.2)                              16 (24.2)                     44 (44.0)                                \<**0.001**
  *blaZ*                                           43 (89.6)                             179 (85.2)                    181 (84.6)                             57 (86.4)                     90 (90.9)                                0.530
  *blaI*                                           43 (89.6)                             177 (85.1)                    191 (91.0)                             57 (86.4)                     91 (91.0)                                0.341
  *blaR*                                           42 (87.5)                             175 (83.3)                    177 (84.3)                             58 (87.9)                     88 (88.9)                                0.653
  *erm(C)*                                         2 (4.2)                               12 (9.1)                      7 (3.3)                                9 (13.6)                      10 (10.0)                                0.018
  *msr(A)*                                         1 (2.1)                               29 (13.7)                     22 (10.3)                              11 (16.7)                     34 (34.0)                                \<**0.001**
  *mphC*                                           1 (2.1)                               22 (18.0)                     21 (10.0)                              8 (17.8)                      32 (33.3)                                \<**0.001**
  *aadD*                                           0 (0.0)                               29 (13.7)                     20 (9.3)                               13 (19.7)                     32 (32.6)                                \<**0.001**
  *aphA3*                                          1 (2.1)                               26 (12.3)                     12 (5.6)                               13 (19.7)                     26 (26.3)                                \<**0.001**
  *sat*                                            1 (2.1)                               23 (11.0)                     10 (4.7)                               12 (18.5)                     26 (26.0)                                \<**0.001**
  *mupR*                                           0 (0.0)                               10 (5.4)                      10 (4.7)                               3 (4.5)                       8 (8.0)                                  0.154
  *fosB*                                           34 (70.8)                             159 (75.7)                    153 (72.2)                             55 (84.6)                     75 (75.0)                                0.295
  **VIRULENCE GENES**                                                                                                                                                                                                                
  *tst1*                                           11 (22.9)                             34 (16.1)                     43 (20.4)                              9 (13.6)                      11 (11.0)                                0.181
  *sea*                                            18 (37.5)                             65 (31.4)                     46 (21.5)                              20 (30.8)                     15 (15.2)                                0.003
  *sec*                                            2 (4.2)                               18 (8.5)                      11 (5.1)                               3 (4.5)                       4 (4.0)                                  0.432
  *sed*                                            10 (20.8)                             8 (4.1)                       23 (11.4)                              0 (0.0)                       6 (6.6)                                  \<**0.001**
  *seg*                                            34 (70.8)                             158 (75.6)                    153 (74.3)                             45 (68.2)                     81 (81.0)                                0.391
  *sei*                                            34 (70.8)                             134 (72.8)                    147 (68.7)                             44 (67.7)                     80 (81.6)                                0.151
  *sel*                                            2 (4.2)                               17 (8.1)                      11 (5.1)                               3 (4.5)                       4 (4.0)                                  0.533
  *selm*                                           36 (75.0)                             136 (73.9)                    154 (72.6)                             45 (68.2)                     84 (84.0)                                0.137
  *seln*                                           34 (70.8)                             139 (75.5)                    149 (70.3)                             45 (68.2)                     81 (81.0)                                0.223
  *selo*                                           27 (56.3)                             125 (700.6)                   144 (68.9)                             42 (64.6)                     79 (79.0)                                0.058
  *egc*                                            35 (72.9)                             168 (79.2)                    165 (77.8)                             45 (68.2)                     83 (83.0)                                0.215
  *selu*                                           34 (70.8)                             164 (77.7)                    150 (70.4)                             45 (68.2)                     83 (83.0)                                0.067
  *lukS*                                           44 (91.7)                             183 (87.6)                    178 (86.4)                             63 (98.4)                     88 (93.6)                                0.011
  *hlgA*                                           47 (97.9)                             196 (94.2)                    204 (95.8)                             61 (93.8)                     97 (98.0)                                0.448
  *lukD*                                           24 (50.0)                             126 (59.4)                    120 (56.1)                             45 (68.2)                     66 (66.0)                                0.152
  *lukE*                                           23 (47.9)                             117 (55.7)                    111 (52.9)                             39 (60.0)                     67 (67.0)                                0.110
  *lukX*                                           41 (85.4)                             190 (93.1)                    191 (90.5)                             63 (95.5)                     92 (92.9)                                0.325
  *hla*                                            40 (83.3)                             187 (88.6)                    187 (93.5)                             64 (97.0)                     97 (97.0)                                0.006
  *un-disr hlb[^α^](#TN11){ref-type="table-fn"}*   9 (18.8)                              87 (41.0)                     54 (26.6)                              8 (12.1)                      15 (15.2)                                \<**0.001**
  *sak*                                            39 (81.3)                             136 (74.3)                    166 (79.8)                             53 (80.3)                     77 (77.0)                                0.669
  *chp*                                            33 (68.8)                             147 (71.7)                    148 (75.1)                             5 (75.8)                      70 (70.7)                                0.814
  *scn*                                            43 (89.6)                             181 (85.8)                    179 (86.1)                             60 (90.9)                     81 (81.8)                                0.497
  *aur*                                            44 (91.7)                             123 (95.3)                    199 (95.2)                             63 (95.5)                     91 (91.9)                                0.686
  *splA*                                           24 (50.0)                             126 (59.4)                    119 (56.4)                             45 (68.2)                     68 (68.7)                                0.084
  *splB*                                           24 (50.0)                             122 (57.5)                    120 (56.3)                             46 (69.7)                     69 (69.0)                                0.044
  *splE*                                           20 (41.7)                             89 (42.6)                     103 (48.1)                             33 (50.0)                     25 (25.0)                                **0.001**
  **CAPSULE-ASSOCIATED GENES**                                                                                                                                                                                                       
  *cap 5*                                          21 (43.8)                             118 (55.7)                    109 (50.9)                             38 (57.6)                     68 (68.0)                                0.026
  *cap 8*                                          28 (58.3)                             96 (45.3)                     105 (49.3)                             28 (42.4)                     32 (32.0)                                0.016
  **MSCRAMM GENES**                                                                                                                                                                                                                  
  *bbp*                                            45 (93.8)                             183 (86.3)                    192 (89.7)                             57 (86.4)                     93 (93.0)                                0.273
  *cna*                                            26 (54.2)                             79 (38.2)                     100 (48.5)                             20 (30.8)                     32 (32.7)                                0.006
  *ebh*                                            45 (93.8)                             194 (91.9)                    190 (89.2)                             64 (97.0)                     90 (90.0)                                0.257
  *fib*                                            28 (58.3)                             132 (62.3)                    126 (59.2)                             51 (77.3)                     71 (71.0)                                0.030
  *sasG*                                           23 47.9                               127 (59.9)                    130 (60.7)                             41 (63.1)                     70 (70.0)                                0.130
  *vwb*                                            44 (91.7)                             197 (92.9)                    212 (99.1)                             63 (96.9)                     99 (99.0)                                0.002
  *isaB*                                           48 (100.0)                            185 (88.5)                    111 (62.7)                             66 (100)                      74 (76.3)                                \<**0.001**

*Multiple comparison*.

*Unknown bacteremia source (169, 20.3%) and other bacteremia sources including respiratory, abdominal and urinary tract infections (24, 2.9%) were not included in this analysis*.

*Ambiguous results from DNA arrays were considered as missing values for further analysis. Variables with an unacceptable proportion of missing values (\>30%) were excluded from analysis*.

*Only the major clones are shown*.

*P-values are calculated for each gene with a two-tailed chi-squared or Fisher\'s exact test, as appropriate. The Bonferroni correction was applied (significant p-value \< 0.001). Statistically significant results are highlighted in bold*.

CRB, catheter-related bacteremia; CC, clonal complex;

*undisrupted hlb; MSCRAMM, microbial surface components recognizing adhesive matrix molecules*.

###### 

Pairwise comparison of clonal complexes, *agr* types and virulence genes according to source of infection.

  **Variable**                                     **Colonization** ***N*** = **48**   **CRB** ***N*** = **212**   **Endocarditis** ***N*** = **214**   **SSTI** ***N*** = **66**   **Osteoarticular** ***N*** = **100**                                                                                                                
  ------------------------------------------------ ----------------------------------- --------------------------- ------------------------------------ --------------------------- -------------------------------------- ---------- ------------ ------------ ---------- ----------- ------------ ---------- ----------- ------------ ----------
  **CC**[^\*^](#TN12){ref-type="table-fn"}                                                                                                                                                                                                                                                                                              
  5                                                9 (19.1)                            190 (31.2)                  0.117                                65 (31.3)                   134 (29.9)                             0.798      47 (22.0)    152 (34.4)   0.002      19 (29.7)   180 (30.4)   1.000      51 (51.5)   148 (26.6)   \< 0.001
  8                                                2 (4.3)                             46 (7.6)                    0.584                                14 (6.7)                    34 (7.6)                               0.817      22 (10.3)    26 (5.9)     0.062      5 (7.8)     43 (7.3)     1.000      3 (3.0)     45 (8.1)     0.092
  15                                               3 (6.4)                             44 (93.6)                   0.788                                15 (7.2)                    193 (92.8)                             0.621      20 (9.3)     194 (32.2)   0.568      10 (15.6)   54 (84.4)    0.043      4 (4.0)     95 (96.0)    0.114
  22                                               2 (4.3)                             45 (95.7)                   0.760                                15 (7.2)                    193 (92.8)                             0.685      16 (7.5)     198 (32.2)   0.541      1 (1.6)     63 (98.4)    0.110      7 (7.1)     92 (92.9)    0.943
  30                                               11 (23.4)                           110 (18.1)                  0.475                                44 (21.2)                   77 (17.2)                              0.267      41 (19.2)    80 (18.1)    0.825      11 (17.2)   110 (18.6)   0.918      11 (11.1)   110 (19.7)   0.057
  45                                               4 (8.5)                             43 (91.5)                   1.000                                19 (9.1)                    189 (90.9)                             0.674      19 (8.9)     195 (91.1)   0.789      3 (4.7)     61 (95.3)    0.346      6 (6.1)     93 (93.9)    0.513
  ***agr*** **TYPES**                                                                                                                                                                                                                                                                                                                   
  *agrI*                                           17 (36.2)                           30 (63.8)                   0.934                                72 (34.1)                   39 (65.9)                              0.942      81 (38.6)    129 (61.4)   0.162      18 (28.1)   46 (71.9)    0.317      28 (28.3)   71 (71.7)    0.190
  *agrII*                                          14 (29.8)                           263 (43.3)                  0.098                                90 (42.7)                   187 (42.2)                             0.982      77 (36.7)    200 (45.0)   0.052      31 (48.4)   246 (41.7)   0.366      55 (55.6)   222 (40.0)   0.006
  *agrIII*                                         12 (25.5)                           35 (74.5)                   0.483                                47 (22.3)                   164 (77.7)                             0.498      46 (21.9)    164 (78.1)   0.608      14 (21.9)   50 (78.9)    0.900      12 (12.1)   87 (87.9)    0.035
  *agrIV*                                          4 (8.5)                             13 (2.1)                    0.028                                2 (0.9)                     15 (3.4)                               0.071      6 (2.8)      11 (2.5)     0.983      1 (1.6)     16 (2.7)     1.000      4 (4.0)     13 (2.3)     0.307
  **ANTIBIOTIC RESISTANCE GENES**                                                                                                                                                                                                                                                                                                       
  *mecA*                                           3 (6.3)                             162 (26.3)                  0.001                                54 (25.5)                   111 (24.6)                             0.875      39 (18.2)    126 (28.0)   0.009      16 (24.2)   149 (24.9)   1.000      44 (44.0)   121 (21.5)   \< 0.001
  *erm (C)*                                        2 (4.2)                             39 (7.3)                    0.564                                12 (9.1)                    29 (6.4)                               0.391      7 (3.3)      34 (9.2)     0.011      9 (13.6)    32 (6.2)     0.049      10 (10.0)   31 (6.4)     0.289
  *msr (A)*                                        1 (2.1)                             102 (16.6)                  0.003                                29 (13.7)                   74 (16.4)                              0.444      22 (10.3)    81 (18.1)    0.013      11 (16.7)   92 (15.4)    0.934      34 (34.0)   69 (12.3)    \< 0.001
  *mphC*                                           1 (2.1)                             86 (17.9)                   0.002                                22 (18.0)                   65 (16.0)                              0.689      21 (10.0)    66 (20.6)    0.002      8 (17.8)    79 (16.3)    0.967      32 (33.3)   55 (12.7)    \< 0.001
  *aadD*                                           0 (0.0)                             101 (16.4)                  0.001                                29 (13.7)                   72 (16.0)                              0.517      20 (9.3)     81 (18.0)    0.005      13 (19.7)   88 (14.7)    0.377      32 (32.6)   69 (12.3)    \< 0.001
  *aphA3*                                          1 (2.1)                             81 (13.2)                   0.021                                26 (12.3)                   56 (12.4)                              1.000      12 (5.6)     70 (15.6)    \< 0.001   13 (19.7)   69 (11.6)    0.089      26 (26.3)   56 (9.9)     \< 0.001
  *sat*                                            1 (2.1)                             76 (12.4)                   0.033                                23 (11.0)                   54 (12.0)                              0.810      10 (4.7)     67 (15.1)    \< 0.001   12 (18.5)   65 (10.9)    0.112      26 (26.0)   51 (9.1)     \< 0.001
  **VIRULENCE GENES**                                                                                                                                                                                                                                                                                                                   
  *sea*                                            18 (37.5)                           155 (25.5)                  0.098                                65 (31.4)                   108 (24.0)                             0.057      46 (21.5)    127 (28.7)   0.063      20 (30.8)   153 (25.8)   0.479      15 (15.2)   158 (28.3)   0.009
  *sed*                                            10 (20.8)                           39 (6.7)                    0.001                                8 (4.1)                     41 (9.6)                               0.027      23 (11.4)    26 (6.1)     0.031      0 (0.0)     49 (8.7)     0.006      6 (6.6)     43 (8.0)     0.793
  *selo*                                           27 (56.3)                           408 (71.0)                  0.049                                125 (70.6)                  310 (69.5)                             0.860      144 (68.9)   291 (70.3)   0.791      42 (64.6)   393 (70.4)   0.410      79 (79.0)   356 (68.1)   0.039
  *selu*                                           34 (70.8)                           460 (74.9)                  0.650                                164 (77.7)                  330 (73.2)                             0.246      150 (70.4)   344 (76.6)   0.106      45 (68.2)   449 (75.3)   0.264      83 (83.0)   411 (73.1)   0.049
  *lukS*                                           44 (91.7)                           532 (89.1)                  0.808                                183 (87.6)                  393 (90.1)                             0.392      178 (86.4)   398 (90.7)   0.136      63 (98.4)   513 (88.3)   0.009      88 (93.6)   488 (88.6)   0.199
  *hla*                                            40 (83.3)                           559 (93.0)                  0.032                                187 (88.6)                  412 (94.1)                             0.023      187 (93.5)   412 (91.8)   0.543      64 (97.0)   535 (91.8)   0.218      97 (97.0)   502 (91.4)   0.086
  *un-disr hlb[^α^](#TN13){ref-type="table-fn"}*   9 (18.8)                            168 (27.8)                  0.234                                87 (41.0)                   90 (20.5)                              \< 0.001   54 (26.6)    123 (27.4)   0.908      8 (12.1)    169 (28.8)   0.006      15 (15.2)   162 (29.3)   0.005
  *splA*                                           24 (50.0)                           374 (61.1)                  0.173                                126 (59.4)                  272 (60.7)                             0.819      119 (56.4)   279 (62.1)   0.187      45 (68.2)   353 (59.4)   0.213      68 (68.7)   330 (58.8)   0.082
  *splB*                                           24 (50.0)                           372 (60.5)                  0.203                                122 (57.5)                  274 (60.8)                             0.484      120 (56.3)   276 (61.3)   0.254      46 (69.7)   350 (58.6)   0.108      69 (69.0)   327 (58.1)   0.052
  *splE*                                           20 (41.7)                           262 (42.7)                  1.000                                89 (42.6)                   193 (42.7)                             1.000      103 (48.1)   179 (40.0)   0.060      33 (50.0)   249 (41.8)   0.255      25 (25.0)   257 (45.8)   \< 0.001
  **CAPSULE-ASSOCIATED GENES**                                                                                                                                                                                                                                                                                                          
  *cap 8*                                          28 (58.3)                           272 (44.2)                  0.082                                96 (45.3)                   204 (45.2)                             1.000      105 (49.3)   195 (43.3)   0.175      28 (42.4)   272 (45.6)   0.722      32 (32.0)   268 (47.6)   0.005
  **MSCRAMM GENES**                                                                                                                                                                                                                                                                                                                     
  *cna*                                            26 (54.2)                           241 (40.2)                  0.081                                79 (38.2)                   188 (42.6)                             0.321      100 (48.5)   167 (37.8)   0.012      20 (30.8)   247 (42.4)   0.095      32 (32.7)   235 (42.7)   0.079
  *fib*                                            28 (58.3)                           396 (64.4)                  0.493                                132 (62.3)                  292 (64.7)                             0.593      126 (59.2)   298 (66.2)   0.092      51 (77.3)   373 (62.5)   0.025      71 (71.0)   353 (62.7)   0.139
  *vwb*                                            44 (91.7)                           592 (96.3)                  0.124                                197 (92.9)                  439 (97.3)                             0.013      212 (99.1)   424 (94.4)   0.003      63 (96.9)   573 (95.8)   1.000      99 (99.0)   537 (95.4)   0.104
  *isaB*                                           48 (100)                            458 (80.1)                  0.001                                185 (88.5)                  321 (78.1)                             0.002      111 (62.7)   395 (89.2)   \< 0.001   66 (100)    440 (79.4)   \< 0.001   74 (76.3)   432 (82.6)   0.183

*Only the major clones are shown*.

SAB, Staphylococcus aureus bacteremia; CRB, catheter-related bacteremia; CC, clonal complex;

*undisrupted hlb; MSCRAMM, microbial surface components recognizing adhesive matrix molecules*.

*P-values are calculated for each gene with a two-tailed chi-squared or Fisher\'s exact test, as appropriate. The Bonferroni correction was applied (significant p-value \< 0.001)*.

A comparison of colonizing vs. SAB strains revealed that the *sed* gene was most frequently found in colonizing strains (20.8 vs. 6.7%, *p* \< 0.001; Table [4B](#T4B){ref-type="table"}). This gene also had greater representation among endocarditis strains (11.4 vs. 6.1%, *p*: 0.031). In addition, the undisrupted *hlb* gene mostly presented in CRB strains (41.0 vs. 20.5%, *p* \< 0.001; Table [4B](#T4B){ref-type="table"}). The presence of MSCRAMM genes, such as *cna, fib, vwb* and *isaB* also varied significantly according to source of SAB. While *cna* and *vwb* genes had greater representation among strains from an endocarditis source (48.5 vs. 37.8%, *p*: 0.012 and 99.1 vs. 94.4%, *p*: 0.003, respectively), there was significant detection of *fib* genes (77.3 vs. 62.5%, *p*: 0.025) in SSTI sources. Finally, the *isaB* gene was more commonly found among CRB strains (88.5 vs. 78.1%, *p*: 0.002) and in the SSTI bacteremia group (100 vs. 79.4%, *p* \< 0.001; Table [4B](#T4B){ref-type="table"}).

Various regression models were performed in order to measure the role of pathogen-related molecular markers (CC, *agr* type and virulence genes) adjusted for different sources of bacteremia and colonization (Table [5](#T5){ref-type="table"}). All adjusted models in multivariate analysis showed that these variables were the presence of *agrIV* type and *sed* gene for colonizing strains; the presence of *sea*, undisrupted *hlb* and *isaB* genes for CRB; *sed, splE* and *fib* genes for an endocarditis source; undisrupted *hlb* for the SSTI group; and finally, CC5, *msrA* resistance gene and *hla* gene with respect to bacteremia from an osteoarticular source (Table [5](#T5){ref-type="table"}).

###### 

Multivariate analysis according to different sources of SAB and colonization.

                                                    **Colonization**     **CRB**    **Endocarditis**    **SSTI**   **Osteoarticular**                                                               
  ------------------------------------------------- -------------------- ---------- ------------------- ---------- -------------------- ---------- ------------------ ------- --------------------- ----------
  *CC5*                                                                                                                                                                       2.05 (1.18--3.64)     0.011
  *agrIV*                                           4.11 (1.24--13.66)   0.021                                                                                                                      
  *mecA*                                            0.18 (0.05--0.060)   0.005                                     --                   --                                                          
  *erm(C)*                                                                                                         --                   --                                                          
  *msr(A)*                                                                                                                                                                    2.55 (1.37--4.75)     0.003
  *aadD*                                                                                                                                                                      --                    --
  *sat*                                                                                                            0.41 (0.19--0.87)    0.021                                                       
  *sea*                                                                             2.06(1.34--3.15)    0.001      0.57 (0.34--0.96)    0.035                                 0.39(0.21--0.72)      0.003
  *sed*                                             5.22 (1.21--12.35)   \< 0.001   0.24(0.09--0.64)    0.004      2.79 (1.33--5.85)    0.007      --                 --                            
  *selu*                                                                                                                                                                      --                    --
  *lukS*                                                                                                                                                                                            
  *hla*                                             0.33 (0.14--0.78)    0.012      0.42 (0.22--0.79)   0.008                                                                 10.01 (1.34--76.01)   0.025
  *un--disr hlb[^α^](#TN15){ref-type="table-fn"}*                                   3.72 (2.42--5.71)   \< 0.001                                   2.5 (1.15--5.46)   0.029   0.30 (0.16--0.56)     \< 0.001
  *splE*                                                                                                           1.56 (1.01--2.43)    0.046                                                       
  *cap 8*                                                                                                                                                                     --                    --
  *cna*                                             --                   --                                                                                                                         
  *fib*                                             --                   --                                        3.42 (1.63--6.44)    0.001                                                       
  *vwb*                                                                             0.35 (0.15--0.80)   0.013                                                                                       
  *isaB*                                                                            2.62 (1.50--4.59)   0.001      0.05 (0.02--0.10)    \< 0.001   --                 --                            

*Various multivariate models were explored that included different numbers of variables according to the number of events by bacteremia source*.

*--: variables included in the initial model of multivariate analysis then discarded in a backward stepwise process. Only variables consistently retained in exploratory models are shown*.

CRB, catheter-related bacteremia; aOR, adjusted Odds Ratio; 95% CI, 95% confidence intervals;

*undisrupted hlb*.

Discussion {#s4}
==========

The present study describes and gives a global epidemiological overview of the molecular epidemiology of a large collection of *S. aureus* strains focused on bloodstream infections in Spain over a 15-years period. In this scenario, our study provides important findings regarding the distribution of clonality and virulence genes and their association with specific sources of SAB.

Our results revealed high clonal diversity among SAB strains, although the most prevalent CCs were CC5, CC30, CC45, CC8, CC15, and CC22, which together represented 80% of all cases. Additionally, substantial differences were found between strains causing MRSA and MSSA bacteremia, which indicated that MSSA strains were much more genetically diverse than their MRSA counterparts, which is consistent with studies developed in Europe (Aamot et al., [@B1]; Grundmann et al., [@B16]) and the USA (Miko et al., [@B25]; Park et al., [@B30]). The most common clone among MSSA strains was CC30, followed by CC45 and CC15, whereas among MRSA strains, there was a significant representation of CC5 in more than 75% of strains. Similar results have been reported in Latin America (Arias et al., [@B2]) and Germany (Schaumburg et al., [@B37]), where the CC5-MRSA clone was the most prevalent in the setting of bloodstream infections. Furthermore, in our collection, CC5 was found to be significantly associated with HA acquisition and the adult population, a finding which lends support to the interest aimed at investigating the pathogenic and molecular characteristics of CC5 and those factors that enhance its spread.

Several studies have suggested that while the *agrI* type is the most common one among clinical isolates (van Leeuwen et al., [@B43]; Moore and Lindsay, [@B27]), others (Sakoulas et al., [@B33]) have determined that more than half of clinical MRSA bloodstream isolates belong to *agr* group *II*. In our collection, *agrII* was also associated with MRSA, which may explain the higher percentage of *agrII* found in the nosocomial setting and among adults, in whom the prevalence of MRSA was higher. By contrast, *agrI* was related to MSSA strains and CA acquisition. Interestingly, a statistically significant association was also found between *agrII* and *agrIII* and adult and child populations, respectively. These associations are probably due to the correlation between *agr* type and CC, since CC5 (*agrII*) was the majority clone among adults and CC30 (*agrIII*) among children.

To date, different studies have explored the association between bacterial genotype, especially *S. aureus* virulence genes, and various clinical syndromes (Gillet et al., [@B14]; Jarraud et al., [@B18]; Peacock et al., [@B31]). This study focuses specifically on bacteremia. Our collection included *S. aureus* strains from the most common primary clinical sources of infection: CRB, SSTI, osteoarticular infection and endocarditis, as well as nasal carriage strains. We found no major differences between colonizing and bacteremia-producing strains of *S. aureus*, which supports the fact that most strains of *S. aureus* are capable of causing bacteremia. Nevertheless, and in accordance with other studies (Fowler et al., [@B11]; Giulieri et al., [@B15]), we identified specific clonal backgrounds and various molecular markers that have been associated with bloodstream infections and certain sources of bacteremia in particular. In this regard, our findings showed that CC5 in addition to *hla* and *msrA* genes were more frequently present in strains causing osteoarticular bacteremia. The association of the *hla* gene, present in most *S. aureus* strains, with different types of infection has already been reported (Stulik et al., [@B41]; Sharma-Kuinkel et al., [@B38]). Further studies are needed to elucidate the role of this important virulence factor in the pathogenesis of bacteremia. With respect to the adhesin genes (MSCRAMMs), which play an essential role in the pathogenesis of intravascular, osteoarticular and device-associated *S. aureus* infections (Foster et al., [@B10]), our study revealed an association between the *fib* and *isaB* genes and endocarditis and CRB sources, respectively. Other adhesins like *clfA/B, fnbA/B*, and *cna* and their linkage with bacteremia, endocarditis and CRB, have also been reported (Giulieri et al., [@B15]; San-Juan et al., [@B35]).

Another finding of note in this study was the presence of the undisrupted β-hemolysin (*undisrupted hlb*) which was significantly related to sources, such as CRB and SSTI. Different studies have demonstrated its contribution to SSTI (Hedström and Malmqvist, [@B17]; Lebughe et al., [@B22]) and biofilm-related infections (Salgado-Pabón et al., [@B34]). Although β-toxin is encoded in *S. aureus*, most strains are reported not to secrete β-toxin because the bacteriophage (ϕSa3) inserts into the *hlb* gene (Winkler et al., [@B47]; Coleman et al., [@B3]), inactivating it in the majority of *S. aureus* strains recovered from humans. Moreover, the ϕSa3 bacteriophage encodes the immune evasion cluster (IEC) *sak-chip-scn* (Coleman et al., [@B4]; de Haas et al., [@B7]). Coinciding with other studies (Pantucek et al., [@B29]; Van Wamel et al., [@B44]), these genes were relatively abundant in our collection, ranging between 73% (*sak*) and 87% (*scn*). Interestingly, the absence of the intact *hlb* gene (or which amounts to the same thing, the presence of *hlb* truncated by the IEC-carrying ϕSa3 phage) was significantly associated with an osteoarticular source. This intriguing association should be investigated further since other studies have reported the association between these phage-integrated genes and less severe staphylococcal infections (Jin et al., [@B19]).

This study presents several limitations that should be mentioned. First, the heterogeneity and non-continuity of the SAB collection (geographical origin, time points and hosts) precluded us from adjusting for these variables in multivariate analysis. Moreover, the proportion of colonization strains was small in comparison with the number of SAB strains. The results therefore should be interpreted with caution. At the same time, our study includes a large number of *S. aureus* strains causing bacteremia, with relevant information on place of acquisition, methicillin resistance and source of infection. Second, the lack of clinical data regarding the outcome of the bacteremic episodes makes it impossible to make inferences about the prognostic importance of the molecular factors. Other studies evaluating associations between bacterial genotype and virulence have led to conflicting results (Day et al., [@B5], [@B6]; Feil et al., [@B8]; Melles et al., [@B24]), due in part to the heterogeneous nature of the *S. aureus* infections included, as well as the absence of a large, well-characterized collection of isolates. Third, our study methodology was based on DNA microarrays, which should be noted in the case of the *hla* gene. Despite the fact that *hla* is present in virtually all *S. aureus* strains, some studies, such as Sharma-kuinkel et al. (JCM) have reported up to 12 different variants of *hla*. In our study, the *hla* gene was detected in 92.2% of strains. We think that the low frequency of this gene observed in our collection may have been due to the DNA microarray technology, which may underestimate the presence of certain minority *hla* variants due to lack of sensitivity. Whole genome sequencing may be a more effective genotypic characterization approach for detecting different genetic variants that may not be detected by hybridization procedures, although previous studies have shown good agreement between the genotypic results obtained using a DNA array-based methodology and those using high-throughput sequencing (Strauß et al., [@B40]). Finally, we did not perform gene expression studies, which would be key to determining whether a particular gene or set of genes was responsible for the specific pathogenic behavior observed in SAB from particular clinical sources. Nevertheless, our findings offer a valuable starting point for further research insights into intrinsic pathogenic mechanisms involved in the development of SAB.

In conclusion, the current study suggests a potential association between *S. aureus* genotype and acquisition, methicillin resistance and bloodstream infection sources. The results of this study reinforce the view that SAB continues to represent a major clinical challenge. Thus, a better understanding of *S. aureus* epidemiology and pathogenesis is crucial to the detection of prognostic biomarkers as well as to the development of potential therapeutic targets aimed at improving patient outcomes.

Author contributions {#s5}
====================

DP-M, EV, and FC conceived and designed the experiments. EV, CG-G, ERG, NL, NF-H, RS, and IM-G collected the isolates. Funding was obtained by FC and BA. Experiments were performed by EV, CG-G, and IM-G. The data were analyzed by EV and DP-M. EV and DP-M prepared the manuscript draft. All authors agreed to be accountable for all aspects of the work. EV, DP-M, and FC contributed in giving final approval of the version to be published. All authors reviewed and approved the final manuscript.

Conflict of interest statement
------------------------------

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

We thank Mercedes Murcia for excellent technical assistance, Jaime Lora-Tamayo for statistical analysis support and Janet Dawson for language support. Moreover, we thank all clinical and microbiological researchers that participated in studies that led to the collection of the *Staphylococcus aureus* strains presented in this study.

**Funding.** This work was supported by the Health Research Fund, Department of Health, Spain; Agency for Health Technology Assessment and Research (PI15/02013 and PI15/02125) and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016-0002; 0003; 0004) and cofunded by the European Regional Development Fund (FEDER).

[^1]: Edited by: Jorge Blanco, Universidade de Santiago de Compostela, Spain

[^2]: Reviewed by: Frieder Schaumburg, Universitätsklinikum Münster, Germany; María Guembe, Hospital General Universitario Gregorio Marañón, Spain; QingZhong Liu, Shanghai Jiao Tong University, China

[^3]: This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology

[^4]: †These authors have contributed equally to this work
